Market Share of Androgen Deprivation Therapy Industry
The androgen deprivation therapy market is moderately competitive. The strategies such as mergers and acquisitions and partnerships adopted by the key players will boost the market. The major players in the market are Johnson and Johnson, AstraZeneca, Bayer AG, Astellas Pharma, Tolmar Pharmaceuticals Inc., and others.
Androgen Deprivation Therapy Market Leaders
Johnson and Johnson
Astrazeneca
Bayer AG
Astellas Pharma Inc.
Tolmar Pharmaceuticals, Inc.
*Disclaimer: Major Players sorted in no particular order
